カテゴリー： 世界, 医療/バイオ, MarketsandMarkets

世界の等温核酸増幅技術（INAAT）市場（～2028年）：製品別（アッセイ、システム）、技術別（LAMP、SDA、NASBA、NEAR、HDA）、用途別（診断（インフルエンザ、肝炎、CT/NG、COVID-19）、血液検査）、エンドユーザー別、地域別

【英語タイトル】Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028

MarketsandMarketsが出版した調査資料（BT2491-23）・商品コード：BT2491-23
・発行会社（調査会社）：MarketsandMarkets
・発行日：2023年3月8日
・ページ数：226
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

MarketsandMarkets社発行の当レポートによると、世界の等温核酸増幅技術（INAAT）市場規模が2023年44億ドルから2028年68億ドルまで、予測期間中、年平均9.2%成長すると予測されています。当レポートは、等温核酸増幅技術（INAAT）の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（アッセイ・キット・試薬、システム）分析、技術別（LAMP、TMA、NEAR、SDA、その他）分析、用途別（疾患診断、血液検査、その他）分析、エンドユーザー別（病院、レファレンスラボ、学術＆研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Grifols, S.A. (Spain)、Hologic, Inc. (US)、Abbott Laboratories (US)、Becton, Dickinson and Company (US)、Meridian Bioscience (US)、Eiken Chemical Co., Ltd. (Japan)、bioMérieux SA (France)、Tecan Trading AG (Switzerland)、New England Biolabs (US)、QIAGEN N.V. (Germany)、DiaSorin S.p.A. (Italy)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要

・世界の等温核酸増幅技術（INAAT）市場規模：製品別
- INAATアッセイ・キット・試薬の市場規模
- INAATシステムの市場規模

・世界の等温核酸増幅技術（INAAT）市場規模：技術別
- LAMP技術の市場規模
- TMA技術の市場規模
- NEAR技術の市場規模
- SDA技術の市場規模
- その他技術の市場規模

・世界の等温核酸増幅技術（INAAT）市場規模：用途別
- 疾患診断における市場規模
- 血液検査における市場規模
- その他用途における市場規模

・世界の等温核酸増幅技術（INAAT）市場規模：エンドユーザー別
- 病院における市場規模
- レファレンスラボにおける市場規模
- 学術＆研究機関における市場規模
- その他エンドユーザーにおける市場規模

・世界の等温核酸増幅技術（INAAT）市場規模：地域別
- 北米の等温核酸増幅技術（INAAT）市場規模
- ヨーロッパの等温核酸増幅技術（INAAT）市場規模
- アジア太平洋の等温核酸増幅技術（INAAT）市場規模
- 中南米の等温核酸増幅技術（INAAT）市場規模
- 中東/アフリカの等温核酸増幅技術（INAAT）市場規模

・競争状況
・企業情報

“等温核酸増幅技術（INAAT）市場は2023年の44億米ドルから2028年には68億米ドルに達し、予測期間中のCAGRは9.2%と予想”
感染症の有病率の増加、INAAT製品のローンチと承認、診断ツールのための資金調達の可能性は、 等温核酸増幅技術（INAAT）市場の成長を促進する要因となります。

“LAMPセグメントがINAAT市場で最大シェアを占める ”
技術に基づき、等温核酸増幅技術（INAAT）は、ループ媒介等温増幅（LAMP）、転写媒介増幅（TMA）、鎖置換増幅（SDA）、ニッキング酵素増幅反応（NEAR）、単一プライマー等温増幅（SPIA）、およびその他の技術にセグメント化されます。2022年には、ループ媒介等温増幅（LAMP）分野が市場を支配しました。これは、LAMPキットの需要が高く、世界中の先進国市場および発展途上国市場でこれらのキットが広く入手可能であるためです。

“感染症診断分野が市場最大のアプリケーション分野を占める”
アプリケーションに基づき、INAAT市場は感染症診断、血液スクリーニング、その他のアプリケーションに区分されます。2022年には疾病診断分野が市場を支配する見込み。HIV、インフルエンザ、肝炎の患者数が世界的に増加していること、感染症対策に注力していること、これらの疾患の診断にINAATベースのキットを使用していることなどが、このセグメントの成長を促進するさまざまな要因です。

等温核酸増幅技術（INAAT）市場の主要企業：
Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK)

“北米が等温核酸増幅技術（INAAT）市場で最大のシェアを占める”
等温核酸増幅技術（INAAT）市場で最大のシェアを占めるのは北米であり、研究資金の確保や診断産業の発展、HIV・肝炎・インフルエンザ患者の早期診断の重要性の高まり、医療インフラの発達などが市場成長の主な要因です。

本レポートのために実施した一次インタビューは以下のように分類されます：
– 回答者別 供給側80%、需要側20%
– 役職別 管理職 – 45%、CXOおよびディレクターレベル – 30%、経営幹部 – 25%
– 地域別 北米 -20%、欧州 -15%、アジア太平洋地域 -55%、その他-10%

レポート掲載企業一覧
• Grifols, S.A. (Spain)
• Hologic, Inc. (US)
• Abbott Laboratories (US)
• Becton, Dickinson and Company (US)
• Meridian Bioscience (US)
• Eiken Chemical Co., Ltd. (Japan)
• bioMérieux SA (France)
• Tecan Trading AG (Switzerland)
• New England Biolabs (US)
• QIAGEN N.V. (Germany)
• DiaSorin S.p.A. (Italy)
• General Electric (US)
• OptiGene Limited (UK)
• Quidel Corporation (US)
• Thermo Fisher Scientific (US)
• Genomtec (Poland)
• Mast Group Ltd. (UK)
• Ustar Biotechnologies (China)
• Jena Bioscience GmbH (Germany)
• Atila BioSystems (US)
• TwistDx Limited (UK)
• LGC Limited (UK)
• Life Sciences Advanced Technologies (US)
• GenoSensor Corporation (US)
• PCR Biosystems (UK) 

調査範囲
この調査レポートは、等温核酸増幅技術（INAAT）市場を詳細に掲載しています。製品、用途、エンドユーザー、地域などの異なるセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの企業プロフィールや最近の動向、主要な市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、等温核酸増幅技術（INAAT）全体とそのサブセグメントにおける収益概算の近似値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場動向を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供することを可能にします。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 35
1.3 MARKET SCOPE 36
FIGURE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION 36
1.3.1 YEARS CONSIDERED 37
1.4 CURRENCY CONSIDERED 37
1.5 LIMITATIONS 37
1.6 STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 2 RESEARCH DESIGN 39
2.1.1 PRIMARY RESEARCH 39
FIGURE 3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 40
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 42
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY RESOURCES 42
2.3 MARKET GROWTH RATE PROJECTIONS 43
FIGURE 7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023–2028 44
FIGURE 8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 44
2.4 DATA TRIANGULATION 45
FIGURE 9 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 45
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT 46
3 EXECUTIVE SUMMARY 48
FIGURE 10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 48
FIGURE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 49
FIGURE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 49
FIGURE 13 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET 51
4 PREMIUM INSIGHTS 52
4.1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW 52
FIGURE 15 INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH 52
4.2 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022) 53
FIGURE 16 ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 53
4.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 2028 53
FIGURE 17 DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 53
4.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 19 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
TABLE 1 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 56
5.2.1.1 Recent launches of INAAT consumables by prominent market players 56
5.2.1.2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics 57
5.2.1.3 High prevalence of infectious diseases 58
5.2.2 RESTRAINTS 58
5.2.2.1 Unfavorable reimbursement scenario for in vitro diagnostic tests 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 INAAT tests as point-of-care tools 59
5.2.3.2 Start-ups focusing on INAAT 59
5.2.4 CHALLENGES 60
5.2.4.1 Dominance of PCR 60
5.3 PRICING ANALYSIS 60
TABLE 2 AVERAGE SELLING PRICE OF INAAT PRODUCTS, 2022 60
5.4 VALUE CHAIN ANALYSIS 61
FIGURE 20 VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 61
5.5 ECOSYSTEM ANALYSIS 62
FIGURE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 62
TABLE 3 SUPPLY CHAIN ECOSYSTEM 63
5.6 KEY CONFERENCES & EVENTS IN 2023–2024 63
TABLE 4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS 63
5.7 PORTER’S FIVE FORCES ANALYSIS 65
TABLE 5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 65
5.7.1 THREAT FROM NEW ENTRANTS 65
5.7.2 THREAT FROM SUBSTITUTES 65
5.7.3 BARGAINING POWER OF BUYERS 65
5.7.4 BARGAINING POWER OF SUPPLIERS 65
5.7.5 DEGREE OF COMPETITION 66
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 66
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS 66
FIGURE 23 BUYING CRITERIA FOR INAAT PRODUCTS 66
5.9 PATENT ANALYSIS 67
FIGURE 24 PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012–DECEMBER 2022 67
5.10 REGULATORY ANALYSIS 67
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
5.10.1 NORTH AMERICA 69
5.10.1.1 US 69
5.10.1.2 Canada 69
5.10.2 EUROPE 69
TABLE 10 EUROPE: CLASSIFICATION OF DEVICES 69
5.10.3 ASIA PACIFIC 70
5.10.3.1 China 70
5.10.3.2 Japan 70
5.10.3.3 India 70
5.10.4 LATIN AMERICA 70
5.10.4.1 Brazil 70
5.10.4.2 Mexico 71
5.10.5 MIDDLE EAST 71
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS 71
6 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 11 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 73
6.2 ASSAYS, KITS, AND REAGENTS 73
6.2.1 GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS 73
TABLE 12 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 74
TABLE 13 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 14 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 15 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
6.3 SYSTEMS 75
6.3.1 GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH 75
TABLE 16 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 17 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 18 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 19 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
7 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY 78
7.1 INTRODUCTION 79
TABLE 20 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES 79
TABLE 21 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 80
7.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) 80
7.2.1 LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH 80
TABLE 22 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 23 NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 24 EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 25 ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
7.3 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 82
7.3.1 GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH 82
TABLE 26 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 27 NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 28 EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 29 ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
7.4 NICKING ENZYME AMPLIFICATION REACTION (NEAR) 84
7.4.1 RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR 84
TABLE 30 NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 31 NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 32 EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 33 ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.5 STRAND DISPLACEMENT AMPLIFICATION (SDA) 86
7.5.1 GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH 86
TABLE 34 STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 35 NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 36 EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 37 ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.6 HELICASE-DEPENDENT AMPLIFICATION (HDA) 88
7.6.1 USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA 88
TABLE 38 HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 39 NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 40 EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 41 ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
7.7 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) 90
7.7.1 ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS 90
TABLE 42 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 43 NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 44 EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 45 ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.8 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) 92
7.8.1 USE OF RNA/DNA-3′ PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET 92
TABLE 46 SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 47 NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 48 EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 49 ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
7.9 OTHER TECHNOLOGIES 95
TABLE 50 OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 51 NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 52 EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 53 ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
8 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION 97
8.1 INTRODUCTION 98
TABLE 54 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 98
8.2 DISEASE DIAGNOSIS 98
TABLE 55 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 56 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 57 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 58 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 59 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100
8.2.1 COVID-19 100
8.2.1.1 Extensive use of INAAT kits for COVID-19 diagnosis to support market growth 100
TABLE 60 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 61 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 62 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 63 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 102
8.2.2 HEPATITIS 102
8.2.2.1 Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth 102
FIGURE 26 NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020 102
TABLE 64 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 65 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 66 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 67 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 104
8.2.3 CT/NG 104
8.2.3.1 Growing prevalence of CT/NG infections worldwide to boost market 104
TABLE 68 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 69 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 70 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 71 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 106
8.2.4 INFLUENZA 106
8.2.4.1 Growing focus on containing spread of influenza to propel growth 106
TABLE 72 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 73 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 74 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 75 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.2.5 HIV 108
8.2.5.1 High global incidence of HIV to support market growth 108
TABLE 76 GLOBAL HIV CASES, 2021 108
TABLE 77 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 78 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 79 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 80 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.2.6 OTHER DISEASES 110
TABLE 81 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 82 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 83 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 84 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 BLOOD SCREENING 111
8.3.1 INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS 111
TABLE 85 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 86 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 87 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 88 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.4 OTHER APPLICATIONS 113
TABLE 89 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 90 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 91 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 92 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115
9 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER 116
9.1 INTRODUCTION 117
TABLE 93 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 117
9.2 HOSPITALS 117
9.2.1 HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD 117
TABLE 94 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 95 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 96 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 97 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 119
9.3 REFERENCE LABORATORIES 119
9.3.1 AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET 119
TABLE 98 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 99 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 100 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 101 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 120
9.4 ACADEMIC & RESEARCH INSTITUTES 121
9.4.1 GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET 121
TABLE 102 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 103 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 104 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 105 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.5 OTHER END USERS 122
TABLE 106 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 107 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 108 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 109 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 124
10 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION 125
10.1 INTRODUCTION 126
TABLE 110 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION) 126
10.2 NORTH AMERICA 126
FIGURE 27 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT 127
TABLE 111 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 112 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 113 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 114 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 115 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 116 NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10.2.1 US 130
10.2.1.1 Increasing approvals of INAAT products to drive market growth 130
TABLE 117 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 118 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 119 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 120 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 121 US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.2.2 CANADA 132
10.2.2.1 Growing demand for molecular diagnostic kits to boost adoption of INAAT 132
TABLE 122 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 123 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 124 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 125 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 126 CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.2.3 NORTH AMERICA: RECESSION IMPACT 135
10.3 EUROPE 135
TABLE 127 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 128 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 129 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 130 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 131 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 132 EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 138
10.3.1 GERMANY 138
10.3.1.1 Germany to dominate European isothermal nucleic acid amplification technology market during forecast period 138
TABLE 133 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 139
TABLE 134 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 135 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 140
TABLE 136 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 137 GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 141
10.3.2 UK 141
10.3.2.1 Growing adoption of INAAT products to support market growth in UK 141
TABLE 138 NUMBER OF BLOOD DONATIONS IN UK, 2016–2020 142
TABLE 139 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 140 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 141 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 142 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 143 UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.3.3 FRANCE 144
10.3.3.1 Established blood screening regulations to boost growth 144
TABLE 144 HIV DATA FOR FRANCE, 2021 145
TABLE 145 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 145
TABLE 146 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 147 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 148 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 149 FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.3.4 ITALY 147
10.3.4.1 Favorable government initiatives for blood transfusion to support growth 147
TABLE 150 HIV DATA FOR ITALY, 2021 147
TABLE 151 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 148
TABLE 152 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 153 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
TABLE 154 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 155 ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.3.5 SPAIN 150
10.3.5.1 Growing demand for diagnostic testing in Spain to favor market growth 150
TABLE 156 HIV DATA FOR SPAIN, 2021 150
TABLE 157 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 158 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 151
TABLE 159 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 160 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 161 SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 152
10.3.6 REST OF EUROPE 153
TABLE 162 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 163 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 164 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 165 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 166 REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.3.7 EUROPE: RECESSION IMPACT 155

10.4 ASIA PACIFIC 156
FIGURE 28 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT 156
TABLE 167 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 168 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 169 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 158
TABLE 170 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 171 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 172 ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 159
10.4.1 CHINA 159
10.4.1.1 China to dominate APAC INAAT market during forecast period 159
TABLE 173 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 174 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 160
TABLE 175 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 176 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 177 CHINA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 161
10.4.2 JAPAN 162
10.4.2.1 Universal healthcare reimbursement policy to drive market growth in Japan 162
TABLE 178 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 179 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 163
TABLE 180 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 181 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 182 JAPAN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 164
10.4.3 INDIA 164
10.4.3.1 Government initiatives for blood donation to contribute to growth 164
TABLE 183 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 165
TABLE 184 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 166
TABLE 185 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 186 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 187 INDIA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 167
10.4.4 REST OF ASIA PACIFIC 167
TABLE 188 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 168
TABLE 189 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 168
TABLE 190 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 191 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 192 REST OF ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 169
10.4.5 ASIA PACIFIC: RECESSION IMPACT 170
10.5 LATIN AMERICA 170
10.5.1 GROWING AWARENESS ABOUT INAAT TO PROPEL GROWTH 170
TABLE 193 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 194 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 195 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172
TABLE 196 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 197 LATIN AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.5.2 LATIN AMERICA: RECESSION IMPACT 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 173
TABLE 198 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 199 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 174
TABLE 200 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 201 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 202 MIDDLE EAST & AFRICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION) 175
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 176
11 COMPETITIVE LANDSCAPE 177
11.1 INTRODUCTION 177
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 177
FIGURE 29 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: STRATEGIES ADOPTED 177
11.3 REVENUE SHARE ANALYSIS 178
FIGURE 30 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022) 178
11.4 MARKET SHARE ANALYSIS 178
FIGURE 31 MARKET SHARE ANALYSIS OF KEY COMPANIES (2022) 179
TABLE 203 INAAT MARKET: DEGREE OF COMPETITION 179
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 180
11.5.1 STARS 180
11.5.2 EMERGING LEADERS 180
11.5.3 PERVASIVE PLAYERS 180
11.5.4 PARTICIPANTS 180
FIGURE 32 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX, 2022 181
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 181
11.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 181
TABLE 204 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 181
11.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 182
TABLE 205 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 182
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 183
TABLE 206 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 183
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 184
11.7.1 PROGRESSIVE COMPANIES 184
11.7.2 STARTING BLOCKS 184
11.7.3 RESPONSIVE COMPANIES 185
11.7.4 DYNAMIC COMPANIES 185
FIGURE 33 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 185
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 186
TABLE 207 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES 186
TABLE 208 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 186
11.9 COMPETITIVE SCENARIO AND TRENDS 187
11.9.1 PRODUCT LAUNCHES 187
TABLE 209 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020– JANUARY 2023 187
11.9.2 DEALS 187
TABLE 210 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: KEY DEALS, JANUARY 2020–JANUARY 2023 187
11.9.3 OTHER DEVELOPMENTS 187
TABLE 211 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020–JANUARY 2023 187
12 COMPANY PROFILES 188
12.1 KEY PLAYERS 188
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats)*
12.1.1 HOLOGIC, INC. 188
TABLE 212 HOLOGIC, INC.: BUSINESS OVERVIEW 188
FIGURE 34 HOLOGIC, INC.: COMPANY SNAPSHOT (2022) 189
12.1.2 ABBOTT LABORATORIES 192
TABLE 213 ABBOTT LABORATORIES: BUSINESS OVERVIEW 192
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 193
12.1.3 GRIFOLS, S.A. 195
TABLE 214 GRIFOLS, S.A.: BUSINESS OVERVIEW 195
FIGURE 36 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021) 196
12.1.4 BECTON, DICKINSON AND COMPANY 198
TABLE 215 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 198
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 199
12.1.5 MERIDIAN BIOSCIENCE 200
TABLE 216 MERIDIAN BIOSCIENCE: BUSINESS OVERVIEW 200
FIGURE 38 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2022) 201
12.1.6 EIKEN CHEMICAL CO., LTD. 203
TABLE 217 EIKEN CHEMICAL CO., LTD.: BUSINESS OVERVIEW 203
FIGURE 39 EIKEN CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2021) 203
12.1.7 QUIDEL CORPORATION 205
TABLE 218 QUIDEL CORPORATION: BUSINESS OVERVIEW 205
FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021) 205
12.1.8 QIAGEN N.V. 207
TABLE 219 QIAGEN N.V.: BUSINESS OVERVIEW 207
FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2021) 208
12.1.9 NEW ENGLAND BIOLABS 209
TABLE 220 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 209
12.1.10 DIASORIN S.P.A. 211
TABLE 221 DIASORIN S.P.A.: BUSINESS OVERVIEW 211
FIGURE 42 DIASORIN S.P.A.: COMPANY SNAPSHOT (2021) 212
12.1.11 BIOMÉRIEUX SA 213
TABLE 222 BIOMÉRIEUX SA: BUSINESS OVERVIEW 213
FIGURE 43 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021) 214
12.1.12 TECAN TRADING GROUP 215
TABLE 223 TECAN TRADING GROUP: BUSINESS OVERVIEW 215
FIGURE 44 TECAN TRADING GROUP: COMPANY SNAPSHOT (2021) 216
12.1.13 GENERAL ELECTRIC COMPANY 217
TABLE 224 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW 217
FIGURE 45 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021) 218
12.1.14 THERMO FISHER SCIENTIFIC 219
TABLE 225 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 219
FIGURE 46 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 220
12.1.15 OPTIGENE LIMITED 222
TABLE 226 OPTIGENE LIMITED: BUSINESS OVERVIEW 222
12.2 OTHER COMPANIES 223
12.2.1 LGC LIMITED 223
12.2.2 USTAR BIOTECHNOLOGIES 223
12.2.3 TWISTDX LIMITED 224
12.2.4 MAST GROUP LTD. 224
12.2.5 GENOMTEC 225
12.2.6 GENOSENSOR CORPORATION 225
12.2.7 JENA BIOSCIENCE GMBH 226
12.2.8 LIFE SCIENCES ADVANCED TECHNOLOGIES 227
12.2.9 PCR BIOSYSTEMS 227
12.2.10 ATILA BIOSYSTEMS 228
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses & competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 229
13.1 DISCUSSION GUIDE 229
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 232
13.3 CUSTOMIZATION OPTIONS 234
13.4 RELATED REPORTS 234
13.5 AUTHOR DETAILS 235

★調査レポート[世界の等温核酸増幅技術（INAAT）市場（～2028年）：製品別（アッセイ、システム）、技術別（LAMP、SDA、NASBA、NEAR、HDA）、用途別（診断（インフルエンザ、肝炎、CT/NG、COVID-19）、血液検査）、エンドユーザー別、地域別] (コード：BT2491-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の等温核酸増幅技術（INAAT）市場（～2028年）：製品別（アッセイ、システム）、技術別（LAMP、SDA、NASBA、NEAR、HDA）、用途別（診断（インフルエンザ、肝炎、CT/NG、COVID-19）、血液検査）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の感染症診断市場（～2028年）：製品・サービス別（試薬、キット）、検査種類別（ラボ、PoC）、サンプル別（血液、尿）、技術別（免疫診断、NGS、PCR、ISH、INAAT）、疾患別（肝炎、HIV、HAI、HPV、梅毒、結核、インフルエンザ）
  • 世界のCT/NG検査市場（～2028年）：製品別（アッセイ・キット、分析器）、検査種類別（研究室検査、ポイントオブケア検査）、技術別（INAAT、PCR、免疫診断）、エンドユーザー別（診断研究所、病院・診療所）、地域別
  • 世界のループ媒介等温増幅マイクロ流体チップ（LAMP）核酸分析装置市場予測 2023年-2029年
  • 世界の核酸増幅検査市場（2023-2030）：種類別（PCR、INAAT）、用途別（感染症検査、がん検査）、エンドユーザー別、地域別
  • 世界の医療用ループ介在等温増幅（LAMP）キット市場予測2023-2029：DNA、RNA

    • ◆H&Iグローバルリサーチのお客様（例）◆